Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.
about
Glucagon and heart in type 2 diabetes: new perspectivesDipeptidyl peptidase-4 and kidney fibrosis in diabetesImprovements in the Management of Diabetic NephropathyIncreased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes.The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.Diabetes-induced mechanophysiological changes in the small intestine and colon.Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin.Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms.Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial.Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?Effects of Incretin-Based Therapies on Diabetic Microvascular Complications.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesDietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.Long-term UVA eye irradiation causes decreased learning ability in mice.Cellular Mechanisms Underlying Obesity-Induced Arterial Stiffness.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.RAGE-dependent mitochondria pathway: a novel target of silibinin against apoptosis of osteoblastic cells induced by advanced glycation end products.
P2860
Q26738580-24FAAC0E-5A48-4C05-BFEA-B2A1307E9BC4Q26766089-AB373D66-9B48-4962-B552-F03E7AB9B5AAQ28080717-3DE37495-6AE3-443D-AC5E-2528B063A86BQ36015232-F9C89F41-A5EB-4420-9E40-5F409C76549BQ37726715-1E202470-EACB-4680-A9B0-5A6287075375Q38936100-4FEC7355-8A03-4EB3-8993-5C4BB7D890FFQ39427195-05AEE4C6-D5DE-4853-96D2-59A9BAE39772Q41107105-1A880753-084C-4EA4-94F7-857369245FAFQ41108574-93429C97-EAC3-4BD8-A9F1-CA84434E80D0Q41395229-4B24E566-FF72-4173-9EBE-B669312674F8Q42115221-0C855CD9-96CA-42BB-9021-76C4FD4822BFQ42175983-59581A93-1946-4658-A4DA-C1438CA3E17FQ42366423-C70429E9-CCEE-48E7-8976-1A6BEE784B3AQ42368137-947DB6A5-3EB0-419D-A43F-292491527DB2Q47658532-48AAFCEF-4712-4046-95B7-9DDC0F9AF03AQ48068714-4A6C290A-A903-49BD-A97C-831166D6514EQ49789137-D9DB749E-6A4F-402F-B229-7FA343693B47Q52688968-CB4EFD0D-AA39-48A3-98A0-EED9EF02EA3CQ55353424-6912FE5F-34D3-4D71-8916-5AEFF45659DF
P2860
Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Crosstalk between advanced gly ...... abetic vascular complications.
@en
type
label
Crosstalk between advanced gly ...... abetic vascular complications.
@en
prefLabel
Crosstalk between advanced gly ...... abetic vascular complications.
@en
P2093
P2860
P921
P1476
Crosstalk between advanced gly ...... abetic vascular complications.
@en
P2093
Kei Fukami
Sho-ichi Yamagishi
Takanori Matsui
P2860
P2888
P356
10.1186/S12933-015-0176-5
P407
P5008
P577
2015-01-13T00:00:00Z
P5875
P6179
1001471007